Vaxcyte, Inc. (PCVX) Misses Q4 EPS by 251c
Get Alerts PCVX Hot Sheet
Join SI Premium – FREE
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($3.44), $2.51 worse than the analyst estimate of ($0.93).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Target raises full-year sales forecast amid ongoing turnaround drive
- FOMC minutes from July 28-29th meeting
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share